{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T08:37:45Z","timestamp":1758703065964},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,11,28]],"date-time":"2012-11-28T00:00:00Z","timestamp":1354060800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12072-012-9411-2","type":"journal-article","created":{"date-parts":[[2012,11,29]],"date-time":"2012-11-29T15:54:33Z","timestamp":1354204473000},"page":"443-450","source":"Crossref","is-referenced-by-count":8,"title":["Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype"],"prefix":"10.1007","volume":"7","author":[{"given":"Wenpeng","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Warner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitina","family":"Sozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilly","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danni","family":"Colledge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Locarnini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A.","family":"Revill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,28]]},"reference":[{"issue":"2","key":"9411_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","volume":"11","author":"D Lavanchy","year":"2004","unstructured":"Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 2004;11(2):97\u2013107","journal-title":"J Viral Hepat"},{"issue":"1","key":"9411_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3748\/wjg.v13.i1.74","volume":"13","author":"J Lupberger","year":"2007","unstructured":"Lupberger J, Hildt E. Hepatitis B virus-induced oncogenesis. World J Gastroenterol 2007;13(1):74\u201381","journal-title":"World J Gastroenterol"},{"issue":"9","key":"9411_CR3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","volume":"2","author":"DM Parkin","year":"2001","unstructured":"Parkin DM. Global cancer statistics in the year 2000. Lancet Oncol 2001;2(9):533\u2013543","journal-title":"Lancet Oncol"},{"issue":"10","key":"9411_CR4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1111\/j.1365-2036.2011.04869.x","volume":"34","author":"WS Ayoub","year":"2011","unstructured":"Ayoub WS, Keeffe EB. Review article: current antiviral therapy of chronic hepatitis B. Aliment Pharmacol Ther 2011;34(10):1145\u20131158","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"9411_CR5","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S0016-5085(03)00939-9","volume":"125","author":"P Angus","year":"2003","unstructured":"Angus P, Vaughan R, Xiong S, et al. Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymerase. Gastroenterology 2003;125(2):292\u2013297","journal-title":"Gastroenterology"},{"issue":"5","key":"9411_CR6","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1053\/j.gastro.2009.08.063","volume":"137","author":"F Zoulim","year":"2009","unstructured":"Zoulim F, Locarnini S. Hepatitis B virus resistance to nucleos(t)ide analogues. Gastroenterology 2009;137(5):1593\u20131608. e1\u2013e2","journal-title":"Gastroenterology"},{"issue":"Suppl 1","key":"9411_CR7","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1016\/S0168-8278(12)60012-9","volume":"56","author":"F Zoulim","year":"2012","unstructured":"Zoulim F, Locarnini S. Management of treatment failure in chronic hepatitis B. J Hepatol 2012;56(Suppl 1):S112\u2013S122","journal-title":"J Hepatol"},{"issue":"1","key":"9411_CR8","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/hep.22295","volume":"48","author":"N Warner","year":"2008","unstructured":"Warner N, Locarnini S. The antiviral drug selected hepatitis B virus rtA181T\/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 2008;48(1):88\u201398","journal-title":"Hepatology"},{"key":"9411_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1186\/1471-2407-11-398","volume":"11","author":"CT Yeh","year":"2011","unstructured":"Yeh CT, Chen T, Hsu CW, et al. Emergence of the rtA181T\/sW172* mutant increased the risk of hepatoma occurrence in patients with lamivudine-resistant chronic hepatitis B. BMC Cancer 2011;11:398","journal-title":"BMC Cancer"},{"issue":"7","key":"9411_CR10","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1177\/135965350801300701","volume":"13","author":"MW Lai","year":"2008","unstructured":"Lai MW, Yeh CT. The oncogenic potential of hepatitis B virus rtA181T\/surface truncation mutant. Antivir Ther 2008;13(7):875\u2013879","journal-title":"Antivir Ther"},{"issue":"8","key":"9411_CR11","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.3851\/IMP1982","volume":"16","author":"BK Kim","year":"2011","unstructured":"Kim BK, Revill PA, Ahn SH. HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B. Antivir Ther 2011;16(8):1169\u20131186","journal-title":"Antivir Ther"},{"issue":"Suppl 1","key":"9411_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/j.1440-1746.2010.06541.x","volume":"26","author":"CL Lin","year":"2011","unstructured":"Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011;26(Suppl 1):123\u2013130","journal-title":"J Gastroenterol Hepatol"},{"issue":"7","key":"9411_CR13","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1128\/AAC.01499-06","volume":"51","author":"N Warner","year":"2007","unstructured":"Warner N, Locarnini S, Kuiper M, et al. The L80I substitution in the reverse transcriptase domain of the hepatitis B virus polymerase is associated with lamivudine resistance and enhanced viral replication in vitro. Antimicrob Agents Chemother 2007;51(7):2285\u20132292. doi: https:\/\/doi.org\/10.1128\/AAC.01499-06. .","journal-title":"Antimicrob Agents Chemother"},{"key":"9411_CR14","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.antiviral.2006.11.014","volume":"75","author":"KWL Yuen","year":"2007","unstructured":"Yuen KWL, Ayres A, Littlejohn M, et al. SEQHEPB: a sequence and analysis program and relational database system for chronic hepatitis B antiviral research. Antivir Res 2007;75:64\u201374","journal-title":"Antivir Res"},{"issue":"1","key":"9411_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1053\/jhep.2003.50012","volume":"37","author":"RY Chen","year":"2003","unstructured":"Chen RY, Edwards R, Shaw T, et al. Effect of the G1896A precore mutation on drug sensitivity and replication yield of lamivudine-resistant HBV in vitro. Hepatology 2003;37(1):27\u201335","journal-title":"Hepatology"},{"issue":"6","key":"9411_CR16","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1002\/hep.23571","volume":"51","author":"AJ Thompson","year":"2010","unstructured":"Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010;51(6):1933\u20131944","journal-title":"Hepatology"},{"issue":"6","key":"9411_CR17","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1128\/AAC.45.6.1705-1713.2001","volume":"45","author":"WEt Delaney","year":"2010","unstructured":"Delaney WEt, Edwards R, Colledge D, et al. Cross-resistance testing of antihepadnaviral compounds using novel recombinant baculoviruses which encode drug-resistant strains of hepatitis B virus. Antimicrob Agents Chemother 2010;45(6):1705\u20131713","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"9411_CR18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1136\/gut.2003.033324","volume":"53","author":"HL Chan","year":"2004","unstructured":"Chan HL, Hui AY, Wong ML, et al. Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma. Gut 2004;53(10):1494\u20131498","journal-title":"Gut"},{"issue":"3","key":"9411_CR19","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1128\/JCM.41.3.1277-1279.2003","volume":"41","author":"HL Chan","year":"2003","unstructured":"Chan HL, Wong ML, Hui AY, et al. Hepatitis B virus genotype C takes a more aggressive disease course than hepatitis B virus genotype B in hepatitis B e antigen-positive patients. J Clin Microbiol 2003;41(3):1277\u20131279","journal-title":"J Clin Microbiol"},{"issue":"7","key":"9411_CR20","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1053\/gast.2002.33588","volume":"122","author":"CJ Chu","year":"2002","unstructured":"Chu CJ, Hussain M, Lok AS. Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. Gastroenterology 2002;122(7):1756\u20131762","journal-title":"Gastroenterology"},{"issue":"5","key":"9411_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1177\/135965350801300501","volume":"13","author":"CJ Liu","year":"2008","unstructured":"Liu CJ, Kao JH. Genetic variability of hepatitis B virus and response to antiviral therapy. Antivir Ther 2008;13(5):613\u2013624","journal-title":"Antivir Ther"},{"issue":"2","key":"9411_CR22","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/135965350801300217","volume":"13","author":"J Wiegand","year":"2008","unstructured":"Wiegand J, Hasenclever D, Tillmann HL. Should treatment of hepatitis B depend on hepatitis B virus genotypes? A hypothesis generated from an explorative analysis of published evidence. Antivir Ther 2008;13(2):211\u2013220","journal-title":"Antivir Ther"},{"issue":"3","key":"9411_CR23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1136\/gut.2006.108928","volume":"56","author":"J Trojan","year":"2007","unstructured":"Trojan J, Stuermer M, Teuber G, Berger A, Faust D. Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer? Gut 2007;56(3):436\u2013437","journal-title":"Gut"},{"issue":"2","key":"9411_CR24","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1136\/gut.2010.223206","volume":"60","author":"SJ Patterson","year":"2011","unstructured":"Patterson SJ, George J, Strasser SI, et al. Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B. Gut 2011;60(2):247\u2013254","journal-title":"Gut"},{"issue":"12","key":"9411_CR25","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1128\/JCM.01518-10","volume":"48","author":"X Li","year":"2010","unstructured":"Li X, Wang L, Zhong Y, et al. Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients. J Clin Microbiol 2010;48(12):4363\u20134369","journal-title":"J Clin Microbiol"},{"issue":"11","key":"9411_CR26","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1002\/jmv.21902","volume":"82","author":"H Damerow","year":"2010","unstructured":"Damerow H, Yuen L, Wiegand J, et al. Mutation pattern of lamivudine resistance in relation to hepatitis B genotypes: hepatitis B genotypes differ in their lamivudine resistance associated mutation pattern. J Med Virol 2010;82(11):1850\u20131858","journal-title":"J Med Virol"},{"issue":"8","key":"9411_CR27","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3851\/IMP1677","volume":"15","author":"JX Yang","year":"2010","unstructured":"Yang JX, Liu BM, Li XG, et al. Profile of HBV antiviral resistance mutations with distinct evolutionary pathways against nucleoside\/nucleotide analogue treatment among Chinese chronic hepatitis B patients. Antivir Ther 2010;15(8):1171\u20131178","journal-title":"Antivir Ther"},{"issue":"3 Pt B","key":"9411_CR28","doi-asserted-by":"publisher","first-page":"471","DOI":"10.3851\/IMP1552","volume":"15","author":"CT Yeh","year":"2010","unstructured":"Yeh CT. Development of HBV S gene mutants in chronic hepatitis B patients receiving nucleotide\/nucleoside analogue therapy. Antivir Ther 2010; 15(3 Pt B):471\u2013475","journal-title":"Antivir Ther"},{"issue":"2","key":"9411_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/135965350901400216","volume":"14","author":"MW Lai","year":"2009","unstructured":"Lai MW, Huang SF, Hsu CW, et al. Identification of nonsense mutations in hepatitis B virus S gene in patients with hepatocellular carcinoma developed after lamivudine therapy. Antivir Ther 2009;14(2):249\u2013261","journal-title":"Antivir Ther"},{"issue":"3","key":"9411_CR30","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","volume":"6","author":"Yun-Fan Liaw","year":"2012","unstructured":"Liaw Y, Kao J, Piratvisuth T, et al. Asian-Pacific Consensus statement on the management of chronic hepatitis B: A 2012 update. Hepatology Int 2012. doi: https:\/\/doi.org\/10.1007\/s12072-012-9365-4 .","journal-title":"Hepatology International"},{"issue":"2","key":"9411_CR31","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1002\/hep.25732","volume":"56","author":"S Locarnini","year":"2012","unstructured":"Locarnini S, Bowden S. Hepatitis B surface antigen quantification: not what it seems on the surface. Hepatology 2012;56(2):411\u2013414","journal-title":"Hepatology"},{"issue":"2","key":"9411_CR32","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3346\/jkms.2010.25.2.257","volume":"25","author":"JH Kim","year":"2010","unstructured":"Kim JH, Jung YK, Joo MK, et al. Hepatitis B viral surface mutations in patients with adefovir resistant chronic hepatitis B with A181T\/V polymerase mutations. J Korean Med Sci 2010;25(2):257\u2013264","journal-title":"J Korean Med Sci"},{"issue":"1","key":"9411_CR33","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jhep.2011.06.028","volume":"56","author":"SA Lee","year":"2012","unstructured":"Lee SA, Kim K, Kim H, Kim BJ. Nucleotide change of codon 182 in the surface gene of hepatitis B virus genotype C leading to truncated surface protein is associated with progression of liver diseases. J Hepatol 2012;56(1):63\u201369","journal-title":"J Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12072-012-9411-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9411-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-012-9411-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T06:16:01Z","timestamp":1687846561000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12072-012-9411-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,28]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9411"],"URL":"https:\/\/doi.org\/10.1007\/s12072-012-9411-2","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,28]]}}}